Overview

Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia Patients

Status:
COMPLETED
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This study aimed to determine the safety and efficacy of thalidomide in multi-transfused thalassemic children.
Phase:
NA
Details
Lead Sponsor:
Muhammad Aamir Latif
Treatments:
Thalidomide